TMDX Q4 2023 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$5B

Q4 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$81M+158.7% YoY

Gross Profit

$48M59.0% margin

Operating Income

$3M3.2% margin

Net Income

$4M5.0% margin

EPS (Diluted)

$0.12

QoQ Revenue Growth

+22.2%

Cash Flow

Operating Cash Flow

$8M

Free Cash Flow

-$34M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$706M

Total Liabilities

$569M

Stockholders' Equity

$137M

Cash & Equivalents

$395M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$81M	$31M	+158.7%
Gross Profit	$48M	$21M	+131.5%
Operating Income	$3M	-$7M	+138.4%
Net Income	$4M	-$7M	+160.0%

Revenue Segments

Product

$89M100%